Photoreceptor layer thinning in idiopathic Parkinson's disease
暂无分享,去创建一个
Shiv Saidha | Friedemann Paul | Thomas Müller | S. Saidha | P. Calabresi | F. Paul | A. Kühn | A. Brandt | T. Müller | H. Zimmermann | Hanna Zimmermann | Peter A. Calabresi | Andrea A. Kühn | Nicolas M. Roth | Alexander U. Brandt | Justine Isensee | Agnieszka Benkhellouf‐Rutkowska | Matthias Dornauer | N. Roth | J. Isensee | Agnieszka Benkhellouf-Rutkowska | Matthias Dornauer
[1] Axel Petzold,et al. Distribution of retinal layer atrophy in patients with Parkinson disease and association with disease severity and duration. , 2014, American journal of ophthalmology.
[2] Han-Joon Kim,et al. Retinal nerve fiber layer thickness and visual hallucinations in Parkinson's Disease , 2014, Movement disorders : official journal of the Movement Disorder Society.
[3] F. Ascaso,et al. Development of a prediction formula of Parkinson disease severity by optical coherence tomography , 2014, Movement disorders : official journal of the Movement Disorder Society.
[4] L. Pablo,et al. Retinal thinning and correlation with functional disability in patients with Parkinson's disease , 2013, British Journal of Ophthalmology.
[5] I. Bodis-Wollner,et al. Correlation of Inner Retinal Thickness Evaluated by Spectral-Domain Optical Coherence Tomography and Contrast Sensitivity in Parkinson disease , 2013, Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society.
[6] G. Ebersbach,et al. Peripheral neuropathy in Parkinson's disease: levodopa exposure and implications for duodenal delivery. , 2013, Parkinsonism & related disorders.
[7] K. Falavarjani,et al. Retinal nerve changes in patients with tremor dominant and akinetic rigid Parkinson’s disease , 2013, Neurological Sciences.
[8] Serkan Kirbas,et al. Retinal Nerve Fiber Layer Thickness in Patients With Alzheimer Disease , 2013, Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society.
[9] L. Pablo,et al. Use of Fourier-domain OCT to detect retinal nerve fiber layer degeneration in Parkinson’s disease patients , 2013, Eye.
[10] G. Rizzo,et al. Loss of temporal retinal nerve fibers in Parkinson disease: a mitochondrial pattern? , 2013, European journal of neurology.
[11] G. Hadjigeorgiou,et al. Perimetric and retinal nerve fiber layer findings in patients with Parkinson’s disease , 2012, BMC Ophthalmology.
[12] L. Pablo,et al. Ability and reproducibility of Fourier-domain optical coherence tomography to detect retinal nerve fiber layer atrophy in Parkinson's disease. , 2012, Ophthalmology (Rochester, Minn.).
[13] I. Bodis-Wollner,et al. Interocular Asymmetry of Foveal Thickness in Parkinson Disease , 2012, Journal of ophthalmology.
[14] Axel Petzold,et al. The OSCAR-IB Consensus Criteria for Retinal OCT Quality Assessment , 2012, PloS one.
[15] A. Schnitzler,et al. Optical Coherence Tomography in Parkinsonian Syndromes , 2012, PloS one.
[16] P. Villoslada,et al. Color vision is strongly associated with retinal thinning in multiple sclerosis , 2012, Multiple sclerosis.
[17] S. A. Meyer,et al. Visual dysfunction in multiple sclerosis correlates better with optical coherence tomography derived estimates of macular ganglion cell layer thickness than peripapillary retinal nerve fiber layer thickness , 2011, Multiple sclerosis.
[18] Amy Conger,et al. The Impact of Utilizing Different Optical Coherence Tomography Devices for Clinical Purposes and in Multiple Sclerosis Trials , 2011, PloS one.
[19] U. Mosimann,et al. Retinal thickness in Parkinson's disease. , 2011, Parkinsonism & related disorders.
[20] C. Pfueller,et al. Impairment of contrast visual acuity as a functional correlate of retinal nerve fibre layer thinning and total macular volume reduction in multiple sclerosis , 2011, British Journal of Ophthalmology.
[21] S. A. Meyer,et al. Primary retinal pathology in multiple sclerosis as detected by optical coherence tomography. , 2011, Brain : a journal of neurology.
[22] Joshua R. Ehrlich,et al. Detection of retinal changes in Parkinson’s disease with spectral-domain optical coherence tomography , 2010, Clinical ophthalmology.
[23] R. Krüger,et al. Complex hyperkinetic movement disorders associated with POLG mutations , 2010, Movement Disorders.
[24] I. Bodis-Wollner. Retinopathy in Parkinson disease , 2009, Journal of Neural Transmission.
[25] I. Bodis-Wollner,et al. Inner retinal layer thinning in Parkinson disease. , 2009, Archives of ophthalmology.
[26] Urs P Mosimann,et al. The retina in Parkinson's disease. , 2009, Brain : a journal of neurology.
[27] P. Witkovsky,et al. Anatomical and neurochemical characterization of dopaminergic interplexiform processes in mouse and rat retinas , 2008, The Journal of comparative neurology.
[28] Y. Çağlar,et al. Correlation between retinal morphological and functional findings and clinical severity in Parkinson’s disease , 2008, Documenta Ophthalmologica.
[29] R. Inzelberg,et al. Retinal nerve fiber layer thinning in Parkinson disease , 2004, Vision Research.
[30] H. Przuntek,et al. Motor impairment influences Farnsworth-Munsell 100 Hue test error scores in Parkinson's disease patients , 2003, Journal of the Neurological Sciences.
[31] L. Murri,et al. Changes in Pattern Electroretinograms to Equiluminant Red-Green and Blue-Yellow Gratings in Patients with Early Parkinson’s Disease , 2003, Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society.
[32] Cynthia Owsley,et al. Visual dysfunction, neurodegenerative diseases, and aging. , 2003, Neurologic clinics.
[33] The Unified Parkinson's Disease Rating Scale (UPDRS): Status and recommendations , 2003, Movement disorders : official journal of the Movement Disorder Society.
[34] A Sahraie,et al. New Farnsworth-Munsell 100 hue test norms of normal observers for each year of age 5–22 and for age decades 30–70 , 2002, The British journal of ophthalmology.
[35] S. Leurgans,et al. Progressive worsening of spatial and chromatic processing deficits in Parkinson disease. , 2002, Archives of neurology.
[36] H. Przuntek,et al. Progress of visual dysfunction in Parkinson's disease , 2002, Acta neurologica Scandinavica.
[37] H. Przuntek,et al. Colour vision abnormalities do not correlate with dopaminergic nigrostriatal degeneration in Parkinson’s disease , 1998, Journal of Neurology.
[38] M. Hankins,et al. Neurobiology of retinal dopamine in relation to degenerative states of the tissue , 1997, Vision Research.
[39] G. Bernardi,et al. Visual alterations in de novo Parkinson's disease , 1995, Neurology.
[40] W. Paulus,et al. Predominant affection of the blue cone pathway in Parkinson's disease. , 1995, Brain : a journal of neurology.
[41] J. Elias,et al. Levodopa improves spatial contrast sensitivity in Parkinson's disease. , 1993, Archives of neurology.
[42] R. Feldman,et al. Abnormalities in color vision and contrast sensitivity in Parkinson's disease , 1992, Neurology.
[43] J. Hughes,et al. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. , 1992, Journal of neurology, neurosurgery, and psychiatry.
[44] T. Di Paolo,et al. Decreased dopamine in the retinas of patients with Parkinson's disease. , 1990, Investigative ophthalmology & visual science.
[45] H. Wagner,et al. GABA and tyrosine hydroxylase immunocytochemistry reveal different patterns of colocalization in retinal neurons of various vertebrates , 1990, The Journal of comparative neurology.
[46] M. Yahr,et al. Visual dysfunction in Parkinson's disease. Loss in spatiotemporal contrast sensitivity. , 1987, Brain : a journal of neurology.
[47] S Nightingale,et al. Visual evoked cortical potentials and pattern electroretinograms in Parkinson's disease and control subjects. , 1986, Journal of neurology, neurosurgery, and psychiatry.
[48] M. Ghilardi,et al. Visual evoked potentials in parkinsonism and dopamine blockade reveal a stimulus-dependent dopamine function in humans. , 1986, Journal of neurology, neurosurgery, and psychiatry.
[49] L. Maffei,et al. Pattern ERG in the monkey after section of the optic nerve , 1986, Behavioural Brain Research.
[50] V C Smith,et al. Color-axis determination on the Farnsworth-Munsell 100-hue test. , 1985, American journal of ophthalmology.
[51] E. Favale,et al. VEP changes in Parkinson's disease are stimulus dependent. , 1984, Journal of neurology, neurosurgery, and psychiatry.
[52] A. Laties,et al. Dopaminergic neurons in the human retina , 1982, The Journal of comparative neurology.
[53] J. Kassubek,et al. Retinal single-layer analysis in Parkinsonian syndromes: an optical coherence tomography study , 2013, Journal of Neural Transmission.
[54] F. Ozturk,et al. The effect of levodopa and dopamine agonists on optic nerve head in Parkinson disease. , 2007, European journal of ophthalmology.
[55] J. Nguyen‐Legros. Functional neuroarchitecture of the retina: hypothesis on the dysfunction of retinal dopaminergic circuitry in Parkinson's disease , 2005, Surgical and Radiologic Anatomy.
[56] Paul Witkovsky,et al. Dopamine and retinal function , 2004, Documenta Ophthalmologica.
[57] J. Friedman. Ophthalmologic features of Parkinson's disease. , 2004, Neurology.
[58] H. Przuntek,et al. Loss of color vision during long-term treatment with pramipexole , 2003, Journal of Neurology.
[59] M Tagliati,et al. The pattern electroretinogram in Parkinson's disease reveals lack of retinal spatial tuning. , 1996, Electroencephalography and clinical neurophysiology.